The development of such technologies has the potential to completely transform the way that we view health care, offering patients the ability to recover from illnesses that have until now been considered incurable — such as neurodegenerative diseases, which can progressively damage organs and tissues over a long period of time. According to a report published in The Lancet in 20181, “neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders.” One of these disorders is Parkinson’s disease, which is estimated to affect more than 10 million people worldwide — more than one million of whom are in Europe.2
Array
Trending Now